Antonio Lo Nigro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Antonio Lo Nigro has a total of 116 co-authors. Here are the top co-authors by number of shared publications:
- Catherine M. Verfaillie
Department of Development and Regeneration, Stem Cell Institute, KU Leuven, Leuven, Belgium
7 shared publications - Felipe Prosper
Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain
4 shared publications - Xabier Lopez Aranguren
Cell Therapy Program, Center for Applied Medical Research (CIMA), University of Navarra, Health Research Institute of Navarra, Pamplona, Spain
4 shared publications - An Zwijsen
Department of Cardiovascular Sciences, KU Leuven
3 shared publications Giulia Coppiello
Cell Therapy Program, Center for Applied Medical Research (CIMA), University of Navarra, Health Research Institute of Navarra, Pamplona, Spain
3 shared publications- Pier Giulio Conaldi
IRCCS ISMETT, 90127 Palermo, Italy
3 shared publications
Latest Publications
- Open Access
- 3 March 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-19
The Wnt/TCF7L1 transcriptional repressor axis drives primitive endoderm formation by antagonizing naive and formative pluripotency
Early during preimplantation development and in heterogeneous mouse embryonic stem cells (mESC) culture, pluripotent cells are specified towards either the primed epiblast or the primitive endoderm (PE) lineage. Canonical Wnt signaling is crucial for safeguarding naive pluripotency and embryo implantation, yet the role and relevance of canonical Wnt inhibition during early mammalian development remains unknown. Here, we demonstrate that transcriptional repression exerted by Wnt/TCF7L1 promotes PE differentiation of mESCs and in preimplantation inner cell mass. Time-series RNA sequencing and promoter occupancy data reveal that TCF7L1 binds and represses genes encoding essential naive pluripotency factors and indispensable regulators of the formative pluripotency program, including Otx2 and Lef1. Consequently, TCF7L1 promotes pluripotency exit and suppresses epiblast lineage formation, thereby driving cells into PE specification. Conversely, TCF7L1 is required for PE specification as deletion of Tcf7l1 abrogates PE differentiation without restraining epiblast priming. Taken together, our study underscores the importance of transcriptional Wnt inhibition in regulating lineage specification in ESCs and preimplantation embryo development as well as identifies TCF7L1 as key regulator of this process.
- 3 March 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-19
Open AccessThe Wnt/TCF7L1 transcriptional repressor axis drives primitive endoderm formation by antagonizing naive and formative pluripotency
Early during preimplantation development and in heterogeneous mouse embryonic stem cells (mESC) culture, pluripotent cells are specified towards either the primed epiblast or the primitive endoderm (PE) lineage. Canonical Wnt signaling is crucial for safeguarding naive pluripotency and embryo implantation, yet the role and relevance of canonical Wnt inhibition during early mammalian development remains unknown. Here, we demonstrate that transcriptional repression exerted by Wnt/TCF7L1 promotes PE differentiation of mESCs and in preimplantation inner cell mass. Time-series RNA sequencing and promoter occupancy data reveal that TCF7L1 binds and represses genes encoding essential naive pluripotency factors and indispensable regulators of the formative pluripotency program, including Otx2 and Lef1. Consequently, TCF7L1 promotes pluripotency exit and suppresses epiblast lineage formation, thereby driving cells into PE specification. Conversely, TCF7L1 is required for PE specification as deletion of Tcf7l1 abrogates PE differentiation without restraining epiblast priming. Taken together, our study underscores the importance of transcriptional Wnt inhibition in regulating lineage specification in ESCs and preimplantation embryo development as well as identifies TCF7L1 as key regulator of this process.
- Open Access
- 1 April 2018
- Published by Elsevier in Journal of Hepatology
- Vol. 68, S40
Ductular reaction cells display an inflammatory profile and recruit neutrophils in alcoholic hepatitis
- 1 April 2018
- Published by Elsevier in Journal of Hepatology
- Vol. 68, S40
Open AccessDuctular reaction cells display an inflammatory profile and recruit neutrophils in alcoholic hepatitis
- 1 August 2017
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 490 (2) , 472-479
In vitro evidences of epithelial to mesenchymal transition in low cell-density cultured human fetal hepatocytes
- 1 August 2017
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 490 (2) , 472-479
In vitro evidences of epithelial to mesenchymal transition in low cell-density cultured human fetal hepatocytes
- Open Access
- 1 May 2017
- Published by Elsevier in Stem Cell Research
- Vol. 21, 47-50
Generation of a Sprague-Dawley-GFP rat iPS cell line
- 1 May 2017
- Published by Elsevier in Stem Cell Research
- Vol. 21, 47-50
Open AccessGeneration of a Sprague-Dawley-GFP rat iPS cell line
- Open Access
- 1 May 2017
- Published by Elsevier in Stem Cell Research
- Vol. 21, 40-43
Isolation and characterization of Sprague-Dawley and Wistar Kyoto GFP rat embryonic stem cells
- 1 May 2017
- Published by Elsevier in Stem Cell Research
- Vol. 21, 40-43
Open AccessIsolation and characterization of Sprague-Dawley and Wistar Kyoto GFP rat embryonic stem cells
- Open Access
- 1 February 2017
- Published by Elsevier in Stem Cell Reports
- Vol. 8 (2) , 318-333
PDGFRα+ Cells in Embryonic Stem Cell Cultures Represent the In Vitro Equivalent of the Pre-implantation Primitive Endoderm Precursors
- 1 February 2017
- Published by Elsevier in Stem Cell Reports
- Vol. 8 (2) , 318-333
Open AccessPDGFRα+ Cells in Embryonic Stem Cell Cultures Represent the In Vitro Equivalent of the Pre-implantation Primitive Endoderm Precursors
- Open Access
- 1 July 2016
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 76, 1-11
PIWI-interacting RNA (piRNA) signatures in human cardiac progenitor cells
- 1 July 2016
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 76, 1-11
Open AccessPIWI-interacting RNA (piRNA) signatures in human cardiac progenitor cells
- Open Access
- 1 August 2015
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 464 (3) , 755-761
Myogenic induction of adult and pluripotent stem cells using recombinant proteins
- 1 August 2015
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 464 (3) , 755-761
Open AccessMyogenic induction of adult and pluripotent stem cells using recombinant proteins
- Open Access
- 21 August 2014
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 32 (11) , 2833-2844
Controlling and Monitoring Stem Cell Safety In Vivo in an Experimental Rodent Model
Adult stem cells have been investigated increasingly over the past years for multiple applications. Although they have a more favorable safety profile compared to pluripotent stem cells, they are still capable of self-renewal and differentiate into several cell types. We investigated the behavior of Oct4-positive (Oct4+) and Oct4-negative (Oct4−) murine or rat bone marrow (BM)-derived stem cells in the healthy brain of syngeneic mice and rats. Engraftment of mouse and rat Oct4-positive BM-derived hypoblast-like stem cells (m/rOct4+ BM-HypoSCs) resulted in yolk-sac tumor formation in the healthy brain which was monitored longitudinally using magnetic resonance imaging (MRI) and bioluminescence imaging (BLI). Contrast enhanced MRI confirmed the disruption of the blood brain barrier. In contrast, m/r Oct4-negative BM-derived multipotent adult progenitor cells (m/rOct4− BM-MAPCs) did not result in mass formation after engraftment into the brain. mOct4+ BM-HypoSCs and mOct4− BM-MAPCs were transduced to express enhanced green fluorescent protein, firefly luciferase (fLuc), and herpes simplex virus-thymidine kinase to follow up suicide gene expression as a potential “safety switch” for tumor-forming stem cells by multimodal imaging. Both cell lines were eradicated efficiently in vivo by ganciclovir administration indicating successful suicide gene expression in vivo, as assessed by MRI, BLI, and histology. The use of suicide genes to prevent tumor formation is in particular of interest for therapeutic approaches where stem cells are used as vehicles to deliver therapeutic genes. Stem Cells 2014;32:2833–2844
- 21 August 2014
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 32 (11) , 2833-2844
Open AccessControlling and Monitoring Stem Cell Safety In Vivo in an Experimental Rodent Model
Adult stem cells have been investigated increasingly over the past years for multiple applications. Although they have a more favorable safety profile compared to pluripotent stem cells, they are still capable of self-renewal and differentiate into several cell types. We investigated the behavior of Oct4-positive (Oct4+) and Oct4-negative (Oct4−) murine or rat bone marrow (BM)-derived stem cells in the healthy brain of syngeneic mice and rats. Engraftment of mouse and rat Oct4-positive BM-derived hypoblast-like stem cells (m/rOct4+ BM-HypoSCs) resulted in yolk-sac tumor formation in the healthy brain which was monitored longitudinally using magnetic resonance imaging (MRI) and bioluminescence imaging (BLI). Contrast enhanced MRI confirmed the disruption of the blood brain barrier. In contrast, m/r Oct4-negative BM-derived multipotent adult progenitor cells (m/rOct4− BM-MAPCs) did not result in mass formation after engraftment into the brain. mOct4+ BM-HypoSCs and mOct4− BM-MAPCs were transduced to express enhanced green fluorescent protein, firefly luciferase (fLuc), and herpes simplex virus-thymidine kinase to follow up suicide gene expression as a potential “safety switch” for tumor-forming stem cells by multimodal imaging. Both cell lines were eradicated efficiently in vivo by ganciclovir administration indicating successful suicide gene expression in vivo, as assessed by MRI, BLI, and histology. The use of suicide genes to prevent tumor formation is in particular of interest for therapeutic approaches where stem cells are used as vehicles to deliver therapeutic genes. Stem Cells 2014;32:2833–2844